299 search results for the keyword medicine supply notification in latest news

Show filters
Sort by

Narrow your results

Latest News

National Patient Safety Alert: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets.

National Patient Safety Alert: Shortage of methylphenidate prolonged-release capsules and tablets, lisdexamfetamine capsules, and guanfacine prolonged-release tablets. National Patient Safety Alert Reference Number: NatPSA/2023/011/DHSC Date issued: 27th September 2023 Brief description of the problem There are supply disruptions affecting various [...]

Published on: 27th September 2023 | Updated on: 27th September 2023

Latest News

National Patient Safety Alert DHSC: Shortage of GLP-1 receptor agonists

Please note this has now been superceded by the NatPSA/2024/001/DHSC Expired National Patient Safety Alert: Shortage of GLP-1 receptor agonists National Patient Safety Alert Reference Number: NatPSA/2023/008/DHSC Date issued: 18th July 2023 Brief description of the problem There are very [...]

Published on: 18th July 2023 | Updated on: 3rd January 2024

Latest News

GLP-1 receptor agonists shortage

The Department of Health and Social Care (DHSC) issued a medicine supply notification for GLP-1 receptor agonists used in the management of type 2 diabetes. We have issued the following comment on the shortage and how community pharmacists will be [...]

Published on: 3rd July 2023 | Updated on: 22nd August 2023

Latest News

Prescription charge to rise to £9.90 on 1 May 2024

The Department of Health and Social Care (DHSC) has announced that from 1st May 2024, the NHS prescription charge will increase to £9.90 per prescription item (note: some items may incur more than one charge). For prescriptions dispensed in April 2024, the NHS [...]

Published on: 4th April 2024 | Updated on: 5th April 2024

Latest News

National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials – Updated

This alert has been superseded by MSN/2024/028 (issued 06/03/2024) National Patient Safety Alert: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials National Patient Safety Alert Reference Number: NatPSA/2024/003/DHSC_MVA Date issued: 26 February 2024 Explanation of identified safety [...]

Published on: 26th February 2024 | Updated on: 6th March 2024

Latest News

Top tips to claim for and reconcile SSP payments

Community Pharmacy England (CPE) has been working with NHS Business Services Authority (NHSBSA) to understand if claims for Serious Shortage Protocols (SSPs) are being submitted correctly. CPE understands that a large number SSP claims continue to be deemed invalid by [...]

Published on: 30th December 2022 | Updated on: 30th December 2022

Latest News

Unplanned temporary closures for reasons beyond a contractor’s control

The current workforce pressures are leading to unplanned temporary closures that are beyond contractors’ control. In these circumstances, if contractors follow appropriate procedures to mitigate the effects of the closure on patients, the public, the NHS, and other community pharmacy [...]

Published on: 7th October 2022 | Updated on: 7th October 2022

Latest News

Contractor Notice: HRT SSP endorsement errors

Following the announcement of thirteen HRT Serious Shortage Protocols (SSP), PSNC has been working with NHS Business Services Authority (NHSBSA) to understand whether claims for HRT SSPs are being submitted correctly and in accordance with the specific supporting guidance for [...]

Published on: 14th July 2022 | Updated on: 13th July 2022

Latest News

Endorsement guidance and FAQs for HRT SSPs now live – update

PSNC’s Dispensing & Supply team have created easy to use flow charts to assist pharmacists in selecting the correct SSP for HRT medicines. These charts also remind contractors of the correct SSP endorsement requirements (with examples) and charge status to [...]

Published on: 27th May 2022 | Updated on: 27th June 2022

Latest News

Supplies made in accordance with HRT SSPs – FAQ briefing and top tips

Following the Department of Health and Social Care’s (DHSC) announcement of three new Serious Shortage Protocols (SSPs) for Hormone Replacement Therapy (HRT) medicines, PSNC has created a briefing titled ‘HRT Serious Shortage Protocols (SSPs) FAQs‘ to help pharmacists understand the requirements of [...]

Published on: 3rd May 2022 | Updated on: 5th June 2022

Latest News

MHRA Drug Safety Update August 2021

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 15 Issue 1 August 2021) has been published and includes articles on: COVID-19 vaccines: updates for July 2021 Letters and medicine recalls sent to healthcare professionals in [...]

Published on: 24th August 2021 | Updated on: 24th August 2021

Latest News

Regs reminder (#9): CAS alert sign-up

Ahead of the 2021/22 contract monitoring process, community pharmacy contractors are reminded of recent changes to the pharmacy Terms of Service. This article is part of a series of reminders. On 20th October 2020 new NHS regulations were laid to introduce changes [...]

Published on: 1st June 2021 | Updated on: 1st June 2021

Latest News

MHRA Drug Safety Update May 2021

The May 2021 Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 10) has been published and includes articles on: Levothyroxine: new prescribing advice for patients who experience symptoms on switching between different levothyroxine products COVID-19 [...]

Published on: 20th May 2021 | Updated on: 20th May 2021

Latest News

MHRA Drug Safety Update April 2021

A new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 14 Issue 8 March 2021) has been published and includes articles on: Polyethylene glycol (PEG) laxatives and starch-based thickeners: potential interactive effect when mixed, leading to an [...]

Published on: 28th April 2021 | Updated on: 28th April 2021